Clinical Trial

Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 17, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center, randomized and controlled phase 3 clinical trial.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-17; most recent amendment 2026-06-15.
Status change: Recruiting → Active, Not Recruiting 2026-06-15
Trial Details
NCT Number NCT06743646
Lead Sponsor Chigenovo Co., Ltd
Conditions Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
Enrollment 62 participants
Start Date 2024-12-27
Primary Completion 2026-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-17